Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Aug 7, 2018
NEW BRUNSWICK, N.J., Aug. 7, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Consumer Staples Conference on Thursday, Sept. 6th, at the InterContinental, Boston, MA.  Jorge Mesquita, Executive Vice President, Worldwide Chairman, Consumer will represent the Company in a session scheduled at 12:45 p.m. (East...
Jul 30, 2018
SKILLMAN, N.J., July 30, 2018 /PRNewswire/ -- Johnson & Johnson Consumer Inc. announced today that it has entered into a definitive agreement to acquire Zarbee's, Inc., a privately held company that is a leader in naturally-based healthcare products.  The acquisition will include the full line of Zarbee's Naturals™ products for children and a...
Jul 17, 2018
NEW BRUNSWICK, N.J., July 17, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $20.8 billion for the second quarter of 2018, an increase of 10.6% as compared to the second quarter of 2017. Operational sales results increased 8.7% and the positive impact of currency was 1.9%. Domestic sales increased 9.4%. International sa...
Jul 16, 2018
NEW BRUNSWICK, N.J., July 16, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2018 of $0.90 per share on the company's common stock.  The dividend is payable on September 11, 2018 to shareholders of record at the close of business on August 28, 2018...
Jul 16, 2018
Jul 11, 2018
Jun 19, 2018
NEW BRUNSWICK, N.J., June 19, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 17, to review second-quarter results.  Alex Gorsky, Chairman and Chief Executive Officer and Joseph J. Wolk, Executive Vice President, Chief Financial Officer will host the call. ...
Jun 18, 2018
SANTA ANA, Calif., June 18, 2018 /PRNewswire/ -- Johnson & Johnson Vision announced today the U.S. Food and Drug Administration (FDA) approval of the iDESIGN Refractive Studio, making it the only system to use topography-integrated, wavefront-guided technology.2 This allows doctors to take a precise measurement of the eye inside and out to deliver ...
Jun 12, 2018
NEW BRUNSWICK, N.J., June 12, 2018 /CNW/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has accepted the binding offer from Platinum Equity, previously announced on March 16, 2018, to acquire its LifeScan business for approximately $2.1 billion. LifeScan, Inc. is a world leader in blood glucose monitoring and maker of the OneTouch® b...
Jun 6, 2018
NEW BRUNSWICK, N.J., June 6, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Fortive Corporation (NYSE: FTV) to acquire its Advanced Sterilization Products (ASP) business, a division of Ethicon, Inc.*, for an aggregate value of approximately $2.8 billion, consisting of $2.7 billion of cas...
Page: FirstPrevious
3
... NextLast
= add release to Briefcase